ChemicalBook >> CAS DataBase List >>Idarucizumab

Idarucizumab

CAS No.
1362509-93-0
Chemical Name:
Idarucizumab
Synonyms
Research Grade Idarucizumab;Research Grade Idarucizumab (DGK09701)
CBNumber:
CB63039317
Molecular Formula:
Molecular Weight:
0
MDL Number:
MOL File:
Mol file
Last updated:2025-04-18 09:51:19

Idarucizumab Properties

FDA UNII 97RWB5S1U6

Idarucizumab Chemical Properties,Uses,Production

Uses

Idarucizumab is a humanized monoclonal antibody fragment. Idarucizumab is first reversal agent for a direct oral anticoagulant (DOAC). Idarucizumab can specifically neutralize the effects of the oral direct thrombin inhibitor in order to restore hemostasis[1].

References

[1] Finks SW, et al. Idarucizumab (Praxbind): The First Reversal Agent for a Direct Oral Anticoagulant. Am J Med. 2017 May;130(5):e195-e197. DOI:10.1016/j.amjmed.2016.11.029

Idarucizumab Preparation Products And Raw materials

Raw materials

Preparation Products

Idarucizumab Suppliers

Global( 10)Suppliers
Supplier Tel Email Country ProdList Advantage
ShangHai Biochempartner Co.,Ltd 177-54423994 17754423994 2853530910@QQ.com China 8000 62
Wuhan Chemstan Biotechnology Co., Ltd. 027-65317797 15926423062 422450190@qq.com China 10308 58
Biolab Reagents 027-65279366 18108604356 products@biolabreagent.com China 9868 58
Wuhan Jingkangen Biomedical Technology Co., Ltd 13720134139 086-15871494362 13720134139 orders@jknbiochem.com China 6613 58
Shanghai Yifei Biotechnology Co. , Ltd. 021-65675885 18964387627 customer_service@efebio.com China 11973 58
Changsha Fuzhen Biotechnology Co.,LTD 0731-13823398 15111215862 313359644@qq.com China 3930 58
Olix (Shanghai) Pharmaceutical Technology Co., Ltd 17316404525 17316404525 209533805@qq.com China 9764 58
Atagenix Laboratories 027-87008169 17762441161 info@atagenix.com China 10001 58
AntibodySystem Laboratories SAS 33175446423 support@antibodysystem.com China 6739 58
Biosynth Biological Technology (Suzhou) Co Ltd 51288865780 sales@biosynth.com China 6051 58
Research Grade Idarucizumab (DGK09701) Research Grade Idarucizumab 1362509-93-0